Table 3 Patient experience and satisfaction with G-CSFa
| Â | Patients |
|---|---|
Concepts related to G-CSF experience, n (%) | N = 21 |
 G-CSF effectiveness | 19 (90) |
 Convenience | 9 (43) |
 Relationship with healthcare provider | 8 (38) |
 Side effects | 7 (33) |
 OBI benefits | 6 (29) |
 More medication | 4 (19) |
 Self-efficacy | 2 (10) |
 Injection discomfort | 2 (10) |
 Sleep interruption | 2 (10) |
 Increased emotional stress | 1 (5) |
 G-CSF not being a cure | 1 (5) |
 Inadequate G-CSF knowledge | 1 (5) |
 Missing work | 1 (5) |
 Insufficient monitoring for subcutaneous G-CSF users | 1 (5) |
Concepts related to G-CSF satisfaction/dissatisfaction, n (%) | N = 17 |
 OBIa | 13 (76) |
 G-CSF effectiveness | 8 (47) |
 Inconvenience | 4 (24) |
 Dose regulation | 3 (18) |